AlphaFold predicted structure
XYLT1 · Q86Y38

Mean pLDDT
81.4/ 100
Confident
959 residues
Confidence breakdown
- Very high(≥ 90)69%
- Confident(70–90)5%
- Low(50–70)3%
- Very low(< 50)24%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
xylosyltransferase 1
Annotations refreshed 1 month ago.
Diagnostic Grade (Green)
Clefting
BIALLELIC, autosomal or pseudoautosomalCongenital disorders of glycosylation
BIALLELIC, autosomal or pseudoautosomalDDG2P
BIALLELIC, autosomal or pseudoautosomalFetal anomalies
BIALLELIC, autosomal or pseudoautosomalIntellectual disability
BIALLELIC, autosomal or pseudoautosomalLikely inborn error of metabolism
BIALLELIC, autosomal or pseudoautosomalSkeletal dysplasia
BIALLELIC, autosomal or pseudoautosomalUndiagnosed metabolic disorders
BIALLELIC, autosomal or pseudoautosomal+1 more panels — install the extension to see the full list inline on any page.
Desbuquois dysplasia 2
Desbuquois syndrome
Desbuquois dysplasia 1
Pseudoxanthoma elasticum
neurodegenerative disease
smoking initiation
XYLT1-congenital disorder of glycosylation
Desbuquois dysplasia
corneal disorder
corneal dystrophy
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Xylosyltransferase 1
Catalyzes the first step in the biosynthesis of chondroitin sulfate and dermatan sulfate proteoglycans, such as DCN. Transfers D-xylose from UDP-D-xylose to specific serine residues of the core protein (PubMed:15461586, PubMed:17189265, PubMed:23982343, PubMed:24581741). Required for normal embryonic and postnatal skeleton development, especially of the long bones (PubMed:23982343, PubMed:24581741). Required for normal maturation of chondrocytes during bone development, and normal onset of ossification (By similarity)
Curated MONDO disease pages that list XYLT1 among their top associated genes.
XYLT1 · Q86Y38

Mean pLDDT
81.4/ 100
Confident
959 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0